A team of researchers at the University of Mississippi has discovered that coating cancer treatment carrying nanoparticles in a sugar-like material increases their treatment efficacy. They reported their findings in Advanced Healthcare Materials.
Over a tenth of breast cancer diagnoses are for triple-negative breast cancer. Triple-negative breast cancer (TNBC) gets its name because it lacks three common targets: estrogen, progesterone, and HER2. It disproportionately affects young women, especially African American women, making it an urgent priority for new treatment strategies.
Mississippi has higher-than-average rates of triple-negative breast cancer. According to a 2024 study from the University of Mississippi Medical Center, 37 % of breast cancer patients treated there between 2016 and 2023 were triple-negative, more than double the national norm.
The aggressive character of this cancer, along with its resistance to several common therapies, results in a greater fatality rate than other cancers.
While this cancer may not increase the levels of usual drug targets, the Ole Miss research team discovered a unique technique to deliver cancer therapies directly to cancer cells.
It doesn’t have any of the usual targets we’ve developed therapies for. That means we really had to think creatively about how to treat it. One thing that is consistent across all of the patients (with triple-negative breast cancer) is that they overexpress glucose transporters to bring more sugars to the cells. Essentially, it has a sweet tooth. So, how can we get it to take its medicine? We wrap it in sugar.
Eden Tanner, Assistant Professor, Chemistry and Biochemistry, The University of Mississippi
Tanner explained that by covering the nanoparticle cancer treatment with sugar, the researchers essentially “trick” the cancer into taking the drug.
When these sugar-coated cancer therapies are put into the bloodstream, they can “hitch a ride” on red and white blood cells. The drug goes through the body like a bus, eventually becoming stuck by the cancer’s glucose transporters.
Because triple-negative breast cancer cells overexpress GLUT-transporters, there is more of an affinity between the nanoparticles and those cells. This method could provide something that will change the way we treat this cancer in the future, and in a way that won’t affect our regular, healthy cells.
Ole Miss junior Mira Patel, co-author of the study.
Triple-negative breast cancer is not the only disease that overexpresses glucose transporters; so, the drug delivery strategy might be applied to treat other diseases.
We haven’t tested the technology on those other diseases yet, but there’s a good reason to believe that a similar strategy might work. That is exciting news for diseases like colon cancer, brain cancer, and fatty liver disease, which also have high levels of glucose transporters.
Eden Tanner, Assistant Professor, Chemistry and Biochemistry, The University of Mississippi
However, the researchers must evaluate the delivery mechanism under disease settings before it can be implemented. Their findings have the potential to save lives in Mississippi since triple-negative breast cancer is so common there.
Journal Reference:
Dasanayake, G. S. et al. (2025) Glyco Ionic Liquids as Novel Nanoparticle Coatings to Enhance Triple-Negative Breast Cancer Drug Delivery. Advanced Healthcare Materials. doi.org/10.1002/adhm.202500592
News
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
